Back to 
Cubist Systematic Strategies, LLC
Cubist Systematic Strategies, LLC
VRTXShowing 0 of 23 quarters
Position history for Cubist Systematic Strategies, LLC's holdings in VERTEX PHARMACEUTICALS INC
No. Cubist Systematic Strategies exited its VRTX (Vertex Pharmaceuticals) position in Q2 2024. Its Q1 2024 13F listed 29,923 shares worth $12.5M. Cubist Systematic Strategies already held VRTX in its Q4 2018 13F, the earliest on record, and held it in 22 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of VRTX: Capital World Investors